SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

Overview Fund Activity

26 hedge funds and large institutions have $16.6M invested in ALPS Medical Breakthroughs ETF in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
6
Closed
5
Calls
$379K
Puts
$554K
Net Calls
-$175K
Net Calls Change
-$481K

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$4.33M
2
VF
2
Virtu Financial
New York
$981K
3
Bank of America
3
Bank of America
North Carolina
$3.53M
4
NAM
4
NTV Asset Management
West Virginia
$420K
5
MCM
5
Murphy Capital Management
New Jersey
$211K

Top Sellers

1
RJA
1
Raymond James & Associates
Florida
$1.01M
2
Credit Agricole
2
Credit Agricole
France
$0
3
LPL Financial
3
LPL Financial
California
$318K
4
Goldman Sachs
4
Goldman Sachs
New York
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
– – -50,036 Closed
Credit Agricole
27
Credit Agricole
France
– – -43,453 Closed
Citadel Advisors
28
Citadel Advisors
Florida
– – -36,239 Closed
Jane Street
29
Jane Street
New York
– – -23,855 Closed
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
– – -9,132 Closed
CG
31
Cutler Group
California
$0 3 +3 New
1
2